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In this work, we integrated prior knowledge from gene signatures and protein interactions
with gene set enrichment analysis (GSEA), and gene/protein network modeling together
to identify gene network signatures from gene expression microarray data. We demon-
strated how to apply this approach into discovering gene network signatures for colorectal
cancer (CRC) from microarray datasets. First, we used GSEA to analyze the microarray
data through enriching differential genes in different CRC-related gene sets from two pub-
licly available up-to-date gene set databases – Molecular Signatures Database (MSigDB)
and Gene Signatures Database (GeneSigDB). Second, we compared the enriched gene
sets through enrichment score, false-discovery rate, and nominal p-value. Third, we con-
structed an integrated protein–protein interaction (PPI) network through connecting these
enriched genes by high-quality interactions from a human annotated and predicted pro-
tein interaction database, with a conﬁdence score labeled for each interaction. Finally,
we mapped differential gene expressions onto the constructed network to build a com-
prehensive network model containing visualized transcriptome and proteome data. The
results show that although MSigDB has more CRC-relevant gene sets than GeneSigDB,
the integrated PPI network connecting the enriched genes from both MSigDB and Gen-
eSigDB can provide a more complete view for discovering gene network signatures. We
also found several important sub-network signatures for CRC, such asTP53 sub-network,
PCNA sub-network, and IL8 sub-network, corresponding to apoptosis, DNA repair, and
immune response, respectively.
Keywords: network biology, gene set enrichment analysis, gene expression signatures, microarray analysis,
colorectal cancer
INTRODUCTION
High-throughput genomics technologies (e.g., gene expres-
sion microarrays) have been tremendously changing biomedical
research nowadays, which allow researchers to simultaneously
monitor the expression of tens of thousands of genes (Allison
et al., 2006). Microarray data analysis has also become a common
practice in many experimental laboratories. Numerous literatures
describe the innovative insights within microarray data analy-
sis (Slonim and Yanai, 2009; Reimers, 2010). It has been widely
applied into many medical areas, including distinguishing disease
subtypes (Sørlie et al., 2001), identifying candidate biomarkers
(Giltnane and Rimm, 2004), and revealing the underlying mole-
cular mechanisms of disease (Segal et al., 2005) or drug response
(Potti et al., 2006).
Gene expressionmicroarrays can take a snapshot of all the tran-
scriptional activity in a biological sample, while it also generates a
huge amount of data with intrinsic noise (sample or instrument
noise), which is still quite a challenging task to interpret even
by exploiting modern computational and statistical tools (Khatri
and Draghici, 2005; Huang et al., 2009; Slonim and Yanai, 2009).
This challenge no longer lies in the acquisition of gene expres-
sion proﬁles, but rather in the interpretation of the results to gain
insights into biological mechanisms (Subramanian et al., 2005).
In many cases, crucial genes show relatively slight changes, and
many genes selected are also poorly annotated (Reimers, 2010).
From a biological perspective, functionally related genes often dis-
play a coordinated expression to accomplish their roles in the cell
(Glez-Pena et al., 2009). In order to translate such lists of differen-
tially expressed genes to a functional proﬁle, researchers presented
many approaches for better understanding the underlying biolog-
ical phenomena. One way to aid such interpretation is looking for
changes in a group of genes with a common function (gene cluster;
Reimers, 2010).
Accordingly, gene set analysis (GSA) methods aim to test the
activity of such gene clusters instead of testing the activity of indi-
vidual genes – individual gene analysis (IGA; Medina et al., 2009).
In recent years,GSAapproachhas received a great deal of attention,
since it is free from the problems of the“cutoff-based”methods. In
this direction, GSA methods enable the understanding of cellular
processes as an intricate network of functionally related compo-
nents (Glez-Pena et al., 2009).Among theseGSAmethods, gene set
enrichment analysis (GSEA) is one of the most widely used meth-
ods (Subramanian et al., 2005). GSEA analyzes pre-deﬁned gene
sets based on prior biological knowledge to determine whether
this gene set as a whole exhibits differential expression. GSEA has
many advantages as it does not employ an arbitrary cutoff to select
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signiﬁcant genes. Instead, it uses all the information about every
gene involved in the experiment (Huang et al., 2009). However,
GSEA does rely on pre-deﬁned gene sets (without gene interac-
tion information), making IGA more beneﬁcial when not much
is known about the biological function being considered (Slonim
and Yanai, 2009). Furthermore, GSEA still assumes that more dif-
ferentially expressed genes are more crucial to the biology, which
is not always true (Huang et al., 2009). In many cases, extensive
upstream data processing, comprehensive gene selection statistics,
and downstream pathway/network analysis cannot be replaced by
GSEA (Huang et al., 2009). Therefore, gene expression signature
analysis and pathway analysis (using tools such as DAVID; Dennis
et al., 2003) remain two separate processes.
Network based gene expression analysis is proposed for can-
didate biomarker discovery by integrating disease susceptibility
genes, their gene expressions, and their gene/protein interaction
network (Chuang et al., 2007; Pujana et al., 2007). In 2007, Marc
Vidal’s group at Harvard constructed a protein interaction net-
work for breast cancer susceptibility using various bioinformatics
data sets, and identiﬁed HMMR as a new susceptibility locus for
the disease (Pujana et al., 2007). Later,Trey Ideker’s group atUCSD
integrated protein network and gene expression data to improve
the prediction of metastasis formation in patients with breast can-
cer (Chuang et al., 2007). The two studies marked the exciting
beginning of a new paradigm which suggests networks and path-
ways, although drafty, error-prone, and incomplete, can serve as a
roadmap to guide future microarray analysis.
Recent advances in genomics, trancriptomics, proteomics,
epigenomics, and metabolomics have begun to help discover
DNA/RNA-based prognostic and predictive markers for early and
advanced colorectal cancer (CRC; Walther et al., 2009). Systems
biology results show that cancer genes and proteins do not func-
tion in isolation; instead, they work in interconnected pathways
and molecular networks (Goymer, 2007). However, systematically
building disease-speciﬁc network models at two levels – tran-
scriptome (mRNA-based signatures from microarray data) and
proteome (protein–protein interaction,PPImarkers fromnetwork
data), has not yet been done in CRC biomarker discovery.
In this paper, we present a computational systems biology
approach based on GSEA and gene/protein network modeling,
which can identify gene network signatures from microarray data
at transcriptome and proteome levels. Using CRC as a case study,
we demonstrate how to apply this approach into discovering
gene network signatures from a CRC-related microarray dataset
from gene expression omnibus (GEO; Edgar et al., 2002). First,
we used GSEA to analyze the microarray data through enrich-
ing differential genes in different CRC-related gene sets from two
publicly available up-to-date gene set databases – Molecular Sig-
natures Database (MSigDB; Subramanian et al., 2005) and Gene
Signatures Database (GeneSigDB; Culhane et al., 2012). Second,
we compared the enriched gene sets through enrichment score
(ES), false-discovery rate (FDR) and nominal p-value. Third, we
constructed an integrated PPI network through connecting these
enriched genes by using a human annotated and predicted pro-
tein interaction (HAPPI) database (Chen et al., 2009), with a
conﬁdence score (CS) labeled for each interaction. Finally, we
map differential expression values onto the constructed network
to build a comprehensive network model containing visualized
genome, transcriptome, and proteome data.
MATERIALS AND METHODS
MICROARRAY DATA
From GEO1, we downloaded a CRC-related microarray dataset –
GSE8671, which compared the transcriptome of 32 prospectively
collected adenomas with those of the normal mucosa from the
same individuals (Sabates-Bellver et al., 2007). Hence we had 32
CRC samples and 32 normal samples. We used maximal expres-
sion values for same proteins mapped from different Probe IDs.
We used Affy package in BioConductor for Quantile normaliza-
tion. For background correction, we used the built-in MicroArray
Suite (MAS5). We used Limma in BioConductor for differential
analysis.
GENE SETS
Gene setswere obtained fromMSigDB2 andGeneSigDB3.MSigDB
has almost 6769 gene sets and are divided in to ﬁve major collec-
tions, of which “C2” are curated gene sets collected from various
sources such as online pathway databases,publications in PubMed,
and knowledge of domain experts. We searched in that collection
with keyword “colon” and obtained 73 gene sets. GeneSigDB is
a manually curated database of gene expression signatures, and it
sharesminimumoverlap betweenMSigDBC2Category of around
8%. It provides the standardized gene list for different search
criteria. Searching as “Colon” retrieved 36 gene sets.
GENE SET ENRICHMENT ANALYSIS
Though there are many variations on the GSEA method, we
describe the version of the algorithm developed by Subraman-
ian and colleagues (Subramanian et al., 2005), which we called
the standard implementation of the method, since it is the most
widely used form of the GSEA method. Suppose that a microarray
dataset is obtained from two different phenotypes, phenotype 1
and phenotype 2 (e.g., control vs. experimental). This microar-
ray dataset has expression values for the genes across the samples
and each row has been identiﬁed by unique probe identiﬁcation.
Consider also a given gene set S, usually derived from some com-
mon biological category. The objective of the GSEA method is to
see if the gene set S shows differential expression between the two
phenotypes.
First, the GSEA method calculates an association score for each
gene that measures the difference of that gene’s expression in
the two phenotypes using any suitable metric. For example, the
association score may be computed for each gene with an indepen-
dent two-sample t -statistic between phenotype 1 and phenotype
2 or the difference between signal-to-noise ratios (mean divided
by variance) in each phenotype. Then it places all the N genes
involved into a list L = {g1, g2, . . ., gN} and sorts the list by each
gene’s association score ri from most positive to most negative.
Genes that appear toward the top of the list are more expressed
in phenotype 1, and genes that appear toward the bottom of the
1http://www.ncbi.nlm.nih.gov/geo/
2http://www.broadinstitute.org/gsea/msigdb/
3http://compbio.dfci.harvard.edu/genesigdb/
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Table 1 | Summary of gene set enrichment analysis (GSEA) results for
the colorectal cancer (CRC) related microarray – GSE8671, based on
the 73 gene sets searched from MSigDB by using query
term – “colon.”
Enrichment Normal vs. cancer Cancer vs. normal
Up-regulated 22 Gene sets 29 Gene sets
Signiﬁcant at FDR <25% 8 Gene sets 14 Gene sets
Nominal p-value <5% 7 Gene sets 12 Gene sets
Nominal p-value <1% 5 Gene sets 6 Gene set
If the number of genes in a gene set falls below the threshold value of 15 in
GSEA, we simply ﬁlled these gene sets out. FDR, false detection rate.
list are more expressed in phenotype 2. Next, GSEA walks down
the gene list and computes a running sum. Each time it hits a gene
in the gene set S, it increases the sum and each time it hits a gene
not in the gene set S, it decreases the sum. The degree to which
the sum is increased or decreased is weighted and normalized so
that the total sum after going through all the genes is 0. Let the ES
to be the maximum deviation of the running sum from 0. More
speciﬁcally, for some weighting parameter p, usually p = 1, let
Phit (S, i) =
∑
gj∈S,j≤i
∣∣rj
∣∣p
NR
, whereNR =
∑
gj
∣∣rj
∣∣p
Pmiss (S, i) =
∑
gj ∈S,j≤i
1
N − NS , where NS = num of genes in S.
Then ES is the maximum deviation of Phit − Pmiss from 0.
In order to determine the signiﬁcance of the ES, the GSEA
method creates a number of permutations and recalculates the
ES for each permutation. Permutations of the phenotypes in the
original microarray data are preferred over permutations of the
genes in the gene list, since this preserves the structure between
genes. The ES’s of the permutations generate a null distribution,
and a nominal p-value is given by the number of permutations
with a larger ES than the original data. This nominal p-value is
then used to help identify whether this gene set is associated with
the difference between the gene expression levels in the samples of
the two phenotypes.
GSEA SOFTWARE AND ANALYSIS SET-UP
The Broad Institute provides an easy to use standalone Java imple-
mentation of the GSEA method on their website4. All gene sets
with more than 500 genes or less than 15 genes were automatically
excluded, according to the default settings. The difference between
signal-to-noise ratios was used as the association score. The num-
ber of phenotype permutations involved in the nominal p-value
calculation was 1000. For each analysis, we report the number of
gene sets with FDR <25%. Along with these gene sets with FDR
<25%,we report the number of gene sets whose nominal p-values
are <1% or 5%. There are some overlap between the three lists of
gene sets, but neither FDR <25% nor nominal p-values <5% are
4http://www.broadinstitute.org/gsea/
FIGURE 1 | Profile of the running ES score and positions of MSigDB
gene set members on the rank ordered list. (A) Enrichment plot for the
gene signature – GRADE_COLON_CANCER_DN, (B) Enrichment plot for
the gene set – SANA_RESPONSE_TO_IFNG_DN.
necessarily subsets of each other. Of course, the collection of gene
sets with nominal p-values <1% is a subset of that with nominal
p-values <5%. Providing results based on all three criteria adds
robustness of the ﬁndings, since each has its own merit.
GENE/PROTEIN NETWORK MODELING
To optimize computation time and information generation, we
used a combined network construction strategy, based on the
enriched genes from both MSigDB and GeneSigDB.
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Table 2 | Summary of gene set enrichment analysis (GSEA) results for
the colorectal cancer (CRC) related microarray – GSE8671, based on
the 36 gene sets searched from GeneSigDB by using query
term – “colon.”
Enrichment Normal vs. cancer Cancer vs. normal
Up-regulated 11 Gene sets 11 Gene sets
Signiﬁcant at FDR <25% 7 Gene sets 8 Gene sets
Nominal p-value <5% 4 Gene sets 5 Gene sets
Nominal p-value <1% 1 Gene sets 2 Gene set
If the number of genes in a gene set falls below the threshold value of 15 in
GSEA, we simply ﬁlled these gene sets out. FDR, false detection rate.
First, we connected the enriched MSigDB genes from
GSE8671in HAPPI5 with CS (CI>= 0.75, i.e., both four-star
and ﬁve-star rating) for high-quality interactions, to obtain a PPI
network. The local topological property (e.g., node degree, clus-
ter coefﬁcient, betweenness centrality, neighborhood connectivity
etc. (Wu and Chen, 2009) for each node was calculated based on
this network. Then genes with absolute fold change |FC|>= 1.5,
equals to Log2(FC)>= 0.585, were kept.
Second, we connected the enriched GeneSigDB genes from
GSE8671 in HAPPI (see text footnote 5) with CS (CI>= 0.75, i.e.,
both four-star and ﬁve-star rating) for high-quality interactions,
to obtain another PPI network. In the same way, the local topolog-
ical property for each node was calculated based on this network.
Then genes with absolute fold change |FC|>= 1.5, equals to Log
2(FC)>= 0.585, were kept.
Finally, we combined these two networks to build a node-
weighted edge-scored CRC-speciﬁc PPI network model by using
Cytoscape (Shannon et al., 2003),with node color representing the
fold change for each gene, node size representing the local topo-
logical property for each gene/protein, edge color, and edge width
representing CS for each protein interaction.
RESULTS
Colorectal cancers arise predominantly from adenomas. We chose
a microarray dataset (GSE8671) which compared the transcrip-
tome of 32 prospectively collected adenomas with those of the
normalmucosa fromthe same individuals.We searched inMsigDB
with keyword “colon” and obtained 73 gene sets. We also searched
in GeneSigDB with keyword “colon” and obtained 34 gene sets.
We ran the GSEA analysis with default values for the microar-
ray dataset-GSE8671 by using gene sets obtained from MSigDB
and GeneSigDB separately. If the number of genes in a gene
set falls below the threshold value of 15 in GSEA, we simply
ﬁlled these gene sets out. PPI data is from HAPPI (foue-star and
ﬁve-star data).
ENRICHED GENE SETS FROM MSigDB
The GSEA analysis using gene sets from MSigDB by applying the
ﬁlter described above resulted 51 gene sets, of which, 22 gene sets
were up-regulated in Normal vs. Cancer, and 29 gene sets were
5http://bio.informatics.iupui.edu/HAPPI
FIGURE 2 | Profile of the running ES score and positions of GeneSigDB
gene set members on the rank ordered list. (A) Enrichment plot for the
gene signature – 16091735-TABLE1, (B) Enrichment plot for the gene
set – 11906190-TABLE2B-2.
up-regulated inCancer vs.Normal. Summary of theGSEAanalysis
result using gene sets from MSigDB are shown in Table 1.
The gene set – GRADE_COLON_CANCER_DN tops the list
with ES of 0.79 in Normal vs. Cancer, and the gene set –
SANA_RESPONSE_TO_IFNG_DN tops the list in Cancer vs.
Normal with the ES of −0.67. The enrichment plots of both the
top gene sets are shown in Figure 1.
Frontiers in Genetics | Systems Biology May 2012 | Volume 3 | Article 80 | 4
Sonachalam et al. Gene network signatures for colorectal cancer
ENRICHED GENE SETS FROM GeneSigDB
The GSEA analysis using gene sets from GeneSigDB by applying
the same ﬁlter results 22 gene sets, of which, 11 gene sets are up-
regulated in Normal vs. Cancer, and 11 gene sets are up-regulated
in Cancer vs. Normal. Summary of the GSEA analysis result using
gene sets from MSigDB are shown in Table 2.
The gene set – 16091735-TABLE1 tops the list in Normal vs.
Cancer with the ES of 0.52 and the gene set – 11906190-TABLE2B-
2 tops the list with ES of −0.53 in Cancer vs. Normal. The
enrichment plots of both the top gene sets are shown in Figure 2.
A PPI NETWORK BASED ON ENRICHED GENES FROM MSigDB
We constructed a PPI network (325 genes and 686 interactions)
with CI>= 0.75 based on the 694 enriched genes (mapped to
678 proteins) from MSigDB, and visualize the network layout by
using spring embedded network layout in Cytoscape 2.8.1. After
ﬁltering out genes with |FC|< 1.5, there were 244 genes and 422
interactions. We also mapped the differential expression values
onto the genes in the network by representing them as node col-
ors. Since we also simply represented node degree as node size, we
could easily access the relationship between differential expression
value and topological property for each gene in the network. As
shown in Figure 3, the gene sets from MSigDB connected very
well. Most important genes associated with CRC, such as TP53,
MDM2, PCNA, HMMR, CHEK2, and MSH2, related to apoptosis
and DNA repair are included. It indicates that MSigDB is suit-
able for GSEA analysis, unsurprisingly, since MSigDB has been
built by the group who also introduced standard GSEA approach
(Subramanian et al., 2005).
A PPI NETWORK BASED ON ENRICHED GENES FROM GeneSigDB
We also constructed a PPI network (112 genes and 169 interac-
tions) with CI>= 0.75 based on the 303 enriched genes (mapped
to 301 proteins) from GeneSigDB, and visualize the network
layout by using spring embedded network layout in Cytoscape
2.8.1. After ﬁltering out genes with |FC|< 1.5, there were only
68 genes and 62 interactions (shown in Figure 4). Although the
gene sets from GeneSigDB are directly from gene expression pro-
ﬁle (most of them are microarray data) analysis, the scale of
the PPI network built on the enriched genes from GeneSigDB
is smaller than the one obtained from MSigDB. It implies that
GeneSigDB may not be applicable for GSEA analysis, at least, can-
not be used singly. Interestingly, although MSigDB contains more
CRC-relevant gene signatures, GeneSigDB includes an important
FIGURE 3 | A PPI network based on the enriched genes from MSigDB by
through analyzing GSE8671 by gene set enrichment analysis (GSEA).The
genes/proteins in the network were obtained from GSEA analysis using
“colon” related gene signatures searched from MSigDB. Node colors
represent differential gene expressions, node size represents the local
topological property, edge color, and edge width represents conﬁdence score
for each protein interaction. Black-circled genes represent the enriched genes
from both MSigDB and GeneSigDB.
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FIGURE 4 | A PPI network based on the enriched genes from GeneSigDB
by through analyzing GSE8671 by gene set enrichment analysis (GSEA).
The genes/proteins in the network were obtained from GSEA analysis using
“colon” related gene signatures searched from GeneSigDB. Node colors
represent differential gene expressions, node size represents the local
topological property, edge color and edge width represents conﬁdence score
for each protein interaction. Black-circled genes represent the enriched genes
from both MSigDB and GeneSigDB.
sub-network-IL18 sub-network, which relates to inﬂammation
and immune response.
AN INTEGRATED CRC-SPECIFIC NETWORK SIGNATURE
There are only 85 genes (mapped to 84 proteins) overlapped
between the 694 enriched genes from MSigDB and the 303
enriched genes from GeneSigDB. So we combine the two PPI
network together to build an integrated network signature spe-
ciﬁc for CRC. We construct a PPI network (443 genes and 1070
interactions) with CI>= 0.75 based on the 895 enriched genes
from both MSigDB and GeneSigDB. After ﬁltering out genes
with |FC|< 1.5, there are 311 genes and 541 interactions (shown
in Figure 5). As we can see, the integrated network has more
genes/proteins connected, especial for the gene sub-network sur-
rounding IL8. This gene has been recognized playing an important
role in regulates various aspects of immune response, cell death,
and differentiation as well as cancer (Raskatov et al., 2012).
DISCUSSION
Pathway and GSEA has evolved in high-throughput functional
genomics study over the last decade (Khatri et al., 2012). Due to
the incomplete information and poor annotation of pathway data,
researchers begin to combine gene set enrichment analysis andnet-
workmodule-based approaches together to identifymore substan-
tial molecular mechanisms. The third generation gene expression
proﬁle analysis (including gene set/pathway/network analysis) can
be deﬁned as a knowledge-guided data-driven method, which is
not only based on the gene sets from prior knowledge, but also
using topology in pathways/networks within or between gene sets
(Khatri et al., 2012). Our work here is toward developing third
generation approaches for identifying disease-speciﬁc network
signatures.
In the ﬁnal CRC network model developed in this paper, node
colors represent differential gene expressions from a“CRC-related
microarray” – transcriptome, node size represents the local topo-
logical property in a“CRC-speciﬁc PPI network”– proteome, edge
color, and edge width represents CS for each protein interaction –
proteome. Most importantly, all the genes/proteins in the network
model are obtained fromGSEA analysis using“colon”-related gene
signatures from both MSigDB and GeneSigDB. Moreover, the
overlapped genes between MSigDB and GeneSigDB are labeled
out with black-circles. We can see that this integrated PPI network
connecting the enriched genes frombothMSigDB andGeneSigDB
can provide more complete view for discovering gene signatures.
This kind of network model for colon/CRC study has NOT been
reported before.
However, gene-to-gene or gene-to-protein interaction may be
even more accurately represented by a network. One limitation of
our restrictive approach and of the GSEA method in general, is
that it is not able to generate new hypotheses for unsuspected gene
sets. This has proved to be a major limitation of the GSEA method
in general, especially since one of themain goals of gene expression
microarray analysis is to ﬁnd new sets of relevant genes. Another
disadvantage of the GSEA method is that genes that are more
differentially expressed are assumed to be more crucial. However,
this assumption has not been thoroughly tested.
Currently, it is important to realize that no single method
of gene expression microarray analysis works best, but rather
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FIGURE 5 | An integrated CRC-specific network signature based on
the enriched genes from both MSigDB and GeneSigDB through
analyzing GSE8671 by gene set enrichment analysis (GSEA).The
genes/proteins in the network were obtained from GSEA analysis using
“colon” related gene signatures searched from both MSigDB and
GeneSigDB. Node colors represent differential gene expressions, node
size represents the local topological property, edge color, and edge
width represents conﬁdence score for each protein interaction.
Black-circled genes represent the enriched genes from both MSigDB
and GeneSigDB.
information generated by the different analyses should be inte-
grated together with the knowledge from biological research. In
future work, we aim to combine GSEA, gene ontology (GO)
enrichment, network expanding/enriching methods together to
identify biologically signiﬁcant genes/proteins. We will use more
gene expression microarray datasets to validate this integrated
strategy. We will also use newly generated gene expression pro-
ﬁles by using RNA-sequencing (RNA-seq) technique to test our
new hypothesis.
CONCLUSION
In this work, we integrated prior knowledge from gene signa-
tures (curated gene sets from MSigDB and GeneSigDB data-
bases) and protein interactions (high-quality interaction data
from HAPPI) with GSEA, and gene/protein network modeling
together to identify gene network signatures from gene expression
microarray data.Wedemonstratedhow to apply this approach into
discovering gene network signatures for CRC from microarray
datasets. The results showed: (1) The MSigDB database con-
tained more CRC-relevant gene signatures than GeneSigDB data-
base did; (2) GeneSigDB database included some important
information which MSigDB database had not; (3) The inte-
grated PPI network connecting the enriched genes from both
MSigDB and GeneSigDB databases can provide a more com-
plete view for discovering gene signatures. We also ﬁnd sev-
eral important sub-network signatures for CRC, such as TP53
sub-network, PCNA sub-network and IL8 sub-network, cor-
responding to apoptosis, DNA repair, and immune response
respectively.
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